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Presacral teratoma in a Curarrino syndrome woman with an unreported
insertion in MNX1 gene
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Accepted 30 June 2010AbstractObjective: Currarino syndrome (CS) comprises a presacral mass, anorectal malformation, and a sacral bony defect. It is rarely reported in the
gynecological field.
Case Report: We describe here the case of a 26-year-old married woman with Currarino syndrome who presented with a presacral teratoma and
a previously unreported insertion in MNX1 gene. She had had a pelvic teratoma diagnosed by laparoscopy 8 years previously. She was referred
to our clinic because of the increasing size of the teratoma and associated compression symptoms. Computed tomography demonstrated
a heterogeneous 12 cm mass in the presacral region. Spina bifida at S2eS5 was also noted. Laparotomy confirmed the diagnosis of presacral
teratoma. Genetic analysis disclosed a triple CGC repeat insertion in exon 1 of MNX1, resulting in three in-frame shifts encoding for the amino
acid alanine. No siblings had known similar symptoms.
Conclusion: Currarino syndrome is known to be an autosomal dominant disorder. The presence of constipation can lead to a diagnosis of the
syndrome early in childhood. In sporadic cases diagnosis is late because of atypical symptoms. Delayed treatment of a presacral tumor may
cause serious complications such as central nervous system infection or subsequent neurological dysfunction. In clinical practice, a presacral
tumor with a sacral bony defect may indicate Currarino syndrome. Genetic analysis of the family may provide information on the hereditary
traits of specific MNX1 mutation.
Copyright  2011, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Currarino syndrome [CS; Online Mendelian Inheritance in
Man (OMIM) no. 176450] is an autosomal dominant disorder
that was first described in 1981 [1]. It is characterized by three
main clinical features: sacral dysgenesis, anorectal malfor-
mation and presacral tumors, resulting from incomplete
separation of the endodermal and ectodermal layers in the
developing embryo. Mutations have been found in MNX1
(motor neuron and pancreas homeobox 1) located at 7q36 in
patients with CS. Here, we describe a previously unreported
insertion in a sporadic case of CS.* Corresponding author. Department of Obstetrics and Gynecology,
Tri-Service General Hospital, No. 325, Section 2, Chenggong Road, Neihu
District, Taipei City 114, Taiwan.
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A 26-year-old married woman, gravida 1, presented at our
clinic with a retroperitoneal tumor about 8 cm in diameter. The
tumor had been known about since a diagnostic laparoscopy
8 years previously had revealed a presacral teratoma. Her
menstrual cycles were regular without dysmenorrhea or
menorrhagia. Computed tomography revealed a heterogeneous
low-attenuation mass about 11.03  8.15 cm in size in the
presacral region with two components and fatty content. Spina
bifida at S2eS5 was also noted (Fig. 1A). Laparotomy showed
a well capsulated cystic mass in the presacral region, con-
sisting of hair and sebaceous tissue and compatible with the
pathology of a mature cystic teratoma. We removed most
tumor parts except for those deeply implanted in the sacral
promontory. Given the clinical features of a presacral tumorcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. (A) Computed tomography scan in a 26-year-old woman showed a presacral tumor measuring about 11.03  8.15 cm with two components and spina bifida
(white star). (B) Genetic analysis of MNX1 in this patient disclosed three CGC (alanine) repeats in exon 1.
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stipation during her teenage years, CS was suspected. Muta-
tion analysis ofMNX1 by sequencing the three exons disclosed
a triple CGC repeat insertion in exon 1, resulting in three in-
frame shifts encoding for the amino acid alanine (Fig. 1B).
The patient developed severe anal pain and intractable diar-
rhea 13 months later, and colorectal surgeons at another
hospital performed a complete resection of a recurrent pre-
sacral teratoma measuring about 6e7 cm.
Discussion
Clinical data and molecular studies have shown overall
mutation detection rates in subjects with CS of about 50%, and
up to 90% in familial cases [2]. To date, more than 66 different
heterozygous mutations have been reported in patients ful-
filling the CS diagnostic criteria, including 10 cytogenetic
anomalies, 29 frameshift mutations, seven nonsense muta-
tions, three splice-site mutations and a total of 17 missensemutations [2]. Most insertions occur at the mutational ‘hot
spot’ in exon 1 with a CCCCCC or a GGGGGG repeat,
resulting in a premature truncation of the protein and loss of
the homeodomain, affecting DNA binding. The pesence of
constipation can lead to a diagnosis of CS early in childhood,
although about 33% of the patients reported showed no clin-
ical symptoms [3].
We report here an observation not previously published,
namely a triple alanine repeat in a patient with CS which may
not cause truncation of the protein. This could explain the
delayed diagnosis of the phenotype in this patient, arising from
a compromised protein function instead of a truncated one.
However, the phenotypes vary widely, without apparent
correlation between the types of MNX1 mutations [4]. Auto-
somal dominant transmission and low clinical penetrance of
CS indicate that the possibility of a multigene disorder and
numbers of patients affected by MNX1 mutations remain
underestimated. Therefore, this syndrome should be consid-
ered for early intervention and genetic testing when patients
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surgical treatment is important to prevent morbidity, particu-
larly when dealing with presacral lesions that can cause teth-
ered cord syndrome, meningitis, chronic neurological
dysfunction, or malignant transformation [5]. A surgical team
including a neurosurgeon, a colorectal surgeon and a gyneco-
logical surgeon might provide better care for patients with CS
presenting with presacral tumors. Genetic testing of the family
might also provide information on the hereditary traits of
specific MNX1 mutations and help explain symptoms that
might develop later in life among patients without truncation
of the MNX1 protein.References
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